Not applicableWithdrawnNCT02001701What this trial is testingIntravitreal Gas for Vitreomacular AdhesionWho this might be right forVitreomacular Adhesion Northern California Retina Vitreous Associates
Not applicableStudy completedNCT02193945What this trial is testingA Retrospective Chart Review of Patients Treated With Ocriplasmin for Symptomatic VMAWho this might be right forSymptomatic Vitreomacular Adhesion (VMA) ThromboGenics 134
Testing effectiveness (Phase 2)Study completedNCT02153476What this trial is testingA Safety And Efficacy Study Of Alg-1001 In Human Subjects With Symptomatic Focal Vitreomacular AdhesionWho this might be right forSymptomatic Focal Vitreomacular Adhesion Allegro Ophthalmics, LLC 45
Large-scale testing (Phase 3)Study completedNCT01889251What this trial is testingA Phase III Study of A01016 in Subjects With Symptomatic Vitreomacular AdhesionWho this might be right forSymptomatic Vitreomacular Adhesion Alcon Research 251
Post-approval studies (Phase 4)Study completedNCT02322229What this trial is testingOcriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular AdhesionWho this might be right forVitreomacular TractionVitreomacular Adhesion Alcon Research 62
Large-scale testing (Phase 3)Study completedNCT01429441What this trial is testingOcriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular HoleWho this might be right forVitreomacular Adhesion Including Macular Hole ThromboGenics 220
Post-approval studies (Phase 4)Study completedNCT02035748What this trial is testingAssessment of Patients Treated With JETREA® for Vitreomacular TractionWho this might be right forVitreomacular TractionVitreomacular Adhesion Alcon Research 628
Not applicableStudy completedNCT02079883What this trial is testingOcriplasmin Research to Better Inform Treatment (ORBIT)Who this might be right forSymptomatic Vitreomacular Adhesion ThromboGenics 540
Not applicableStudy completedNCT01287988What this trial is testingFollow-up Study to Assess Visual Function in Subset of Patients Who Have Previously Participated in the TG-MV-006 and TG-MV-007 Ocriplasmin StudiesWho this might be right forSymptomatic Vitreomacular Adhesion ThromboGenics 24